IL6 and COVID-19: The levels of the pro-inflammatory cytokine IL-6 were generally increased at diagnosis in the COVID-19 male patients, while they were decreased in the same patients at follow-up but were still elevated after 5 months compared to healthy controls (p = 0.049, Figure 2A).